4
Changes in Ownership
Evofem Biosciences, Inc. Filed Acc 0001209191-15-081396
Chief Scientific Officer sold 6,098 shares at $8.30 ($50,619)
- Chief Scientific Officer acquired 6,098 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Locke Kenneth W Chief Scientific Officer | 2015-11-18 | Option exercise | +6,098 | $8.30 | $50,619 | 6,391 | D |
| Locke Kenneth W Chief Scientific Officer | 2015-11-18 | Sale | −6,098 | $8.30 | $50,619 | 293 | D |
| Derivatives | |||||||
| Locke Kenneth W Chief Scientific Officer | 2015-11-18 | Option exercise · Stock Option (Right to Buy) | −4,093 | 23,191 | D | ||
| Locke Kenneth W Chief Scientific Officer | 2015-11-18 | Option exercise · Stock Option (Right to Buy) | −2,005 | 11,366 | D | ||
| Open-market sales · 6,098 sh · avg $8.30 · $50,619 | |||||||
Loading xslF345X03/doc4.xml…